Humaira Gowher
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Humaira Gowher has a total of 125 co-authors. Here are the top co-authors by number of shared publications:
- Allison B. Norvil
Department of Biochemistry, Purdue University, West Lafayette, IN 47907, USA
10 shared publications Ming He
Department of Biochemistry, Purdue University. West Lafayette, Indiana 47907, USA
10 shared publications- Isaiah K. Mensah
Department of Pathology & Immunology, Washington University in St. Louis , St. Louis, MO
6 shared publications Lama AlAbdi
Department of Zoology, Collage of Science, King Saud University , Riyadh, Saudi Arabia
5 shared publicationsMohd Saleem Dar
Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA
4 shared publicationsBigang Liu
Department of Epigenetics and Molecular Carcinogenesis, Division of Basic Sciences, The University of Texas MD Anderson Cancer Center, Smithville, TX 78957, USA
3 shared publications
Latest Publications
- Open Access
VEZF1 facilitates pluripotency exit by regulating developmental transcriptional programs and CTCF occupancy
Vascular Endothelial Zinc Finger 1 (VEZF1) is essential for embryonic development, but its role in pluripotent state transitions remains unclear. Previous work showed that Vezf1 -/- ESCs exhibit impaired differentiation, reduced Dnmt3b expression, and genome-wide hypomethylation. Here, our systematic investigation shows that VEZF1 is required for pluripotency exit during ESC differentiation. Vezf1 -/- ESCs fail to efficiently repress the pluripotency transcriptional program during differentiation, a defect that persists despite ectopic Dnmt3b expression. Genome-wide analysis revealed VEZF1 occupancy at regulatory regions of genes involved in several signaling pathways, including MAPK, as well as at some pluripotency-associated genes. Many VEZF1- bound MAPK genes showed reduced expression in undifferentiated Vezf1 -/- ESCs, suggesting that VEZF1 activity contributes to the transcriptional competence required for efficient differentiation. VEZF1 loss also led to widespread acquisition of new CTCF sites associated with developmental signaling, a subset of which overlapped VEZF1-bound regulatory regions. CTCF depletion partially rescued the expression of several tested MAPK pathway genes, indicating that altered CTCF occupancy contributes to their reduced expression in Vezf1 -/- ESCs. Together, our findings identify a novel function for VEZF1 in coordinating pluripotency exit with expression of pro- differentiation signaling genes and reveal a functional interplay between VEZF1 and CTCF during cell state transitions.
Open AccessVEZF1 facilitates pluripotency exit by regulating developmental transcriptional programs and CTCF occupancy
Vascular Endothelial Zinc Finger 1 (VEZF1) is essential for embryonic development, but its role in pluripotent state transitions remains unclear. Previous work showed that Vezf1 -/- ESCs exhibit impaired differentiation, reduced Dnmt3b expression, and genome-wide hypomethylation. Here, our systematic investigation shows that VEZF1 is required for pluripotency exit during ESC differentiation. Vezf1 -/- ESCs fail to efficiently repress the pluripotency transcriptional program during differentiation, a defect that persists despite ectopic Dnmt3b expression. Genome-wide analysis revealed VEZF1 occupancy at regulatory regions of genes involved in several signaling pathways, including MAPK, as well as at some pluripotency-associated genes. Many VEZF1- bound MAPK genes showed reduced expression in undifferentiated Vezf1 -/- ESCs, suggesting that VEZF1 activity contributes to the transcriptional competence required for efficient differentiation. VEZF1 loss also led to widespread acquisition of new CTCF sites associated with developmental signaling, a subset of which overlapped VEZF1-bound regulatory regions. CTCF depletion partially rescued the expression of several tested MAPK pathway genes, indicating that altered CTCF occupancy contributes to their reduced expression in Vezf1 -/- ESCs. Together, our findings identify a novel function for VEZF1 in coordinating pluripotency exit with expression of pro- differentiation signaling genes and reveal a functional interplay between VEZF1 and CTCF during cell state transitions.
- Open Access
Multimodal Quantum Vision Transformer for Enzyme Commission Classification from Biochemical Representations
Accurately predicting enzyme functionality remains one of the major challenges in computational biology, particularly for enzymes with limited structural annotations or sequence homology. We present a novel multimodal Quantum Machine Learning (QML) framework that enhances Enzyme Commission (EC) classification by integrating four complementary biochemical modalities: protein sequence embeddings, quantum-derived electronic descriptors, molecular graph structures, and 2D molecular image representations. Quantum Vision Transformer (QVT) backbone equipped with modality-specific encoders and a unified cross-attention fusion module. By integrating graph features and spatial patterns, our method captures key stereoelectronic interactions behind enzyme function. Experimental results demonstrate that our multimodal QVT model achieves a top-1 accuracy of 85.1%, outperforming sequence-only baselines by a substantial margin and achieving better performance results compared to other QML models.
Open AccessMultimodal Quantum Vision Transformer for Enzyme Commission Classification from Biochemical Representations
Accurately predicting enzyme functionality remains one of the major challenges in computational biology, particularly for enzymes with limited structural annotations or sequence homology. We present a novel multimodal Quantum Machine Learning (QML) framework that enhances Enzyme Commission (EC) classification by integrating four complementary biochemical modalities: protein sequence embeddings, quantum-derived electronic descriptors, molecular graph structures, and 2D molecular image representations. Quantum Vision Transformer (QVT) backbone equipped with modality-specific encoders and a unified cross-attention fusion module. By integrating graph features and spatial patterns, our method captures key stereoelectronic interactions behind enzyme function. Experimental results demonstrate that our multimodal QVT model achieves a top-1 accuracy of 85.1%, outperforming sequence-only baselines by a substantial margin and achieving better performance results compared to other QML models.
- 5 June 2025
- Published by Elsevier in Future Generation Computer Systems
- Vol. 174
Multi-omic and quantum machine learning integration for lung subtypes classification
- 5 June 2025
- Published by Elsevier in Future Generation Computer Systems
- Vol. 174
Multi-omic and quantum machine learning integration for lung subtypes classification
- Open Access
Multi-Omic and Quantum Machine Learning Integration for Lung Subtypes Classification
Quantum Machine Learning (QML) is a red-hot field that brings novel discoveries and exciting opportunities to resolve, speed up, or refine the analysis of a wide range of computational problems. In the realm of biomedical research and personalized medicine, the significance of multi-omics integration lies in its ability to provide a thorough and holistic comprehension of complex biological systems. This technology links fundamental research to clinical practice. The insights gained from integrated omics data can be translated into clinical tools for diagnosis, prognosis, and treatment planning. The fusion of quantum computing and machine learning holds promise for unraveling complex patterns within multi-omics datasets, providing unprecedented insights into the molecular landscape of lung cancer. Due to the heterogeneity, complexity, and high dimensionality of multi-omic cancer data, characterized by the vast number of features (such as gene expression, micro-RNA, and DNA methylation) relative to the limited number of lung cancer patient samples, our prime motivation for this paper is the integration of multi-omic data, unique feature selection, and diagnostic classification of lung subtypes: lung squamous cell carcinoma (LUSC-I) and lung adenocarcinoma (LUAD-II) using quantum machine learning. We developed a method for finding the best differentiating features between LUAD and LUSC datasets, which has the potential for biomarker discovery.
Open AccessMulti-Omic and Quantum Machine Learning Integration for Lung Subtypes Classification
Quantum Machine Learning (QML) is a red-hot field that brings novel discoveries and exciting opportunities to resolve, speed up, or refine the analysis of a wide range of computational problems. In the realm of biomedical research and personalized medicine, the significance of multi-omics integration lies in its ability to provide a thorough and holistic comprehension of complex biological systems. This technology links fundamental research to clinical practice. The insights gained from integrated omics data can be translated into clinical tools for diagnosis, prognosis, and treatment planning. The fusion of quantum computing and machine learning holds promise for unraveling complex patterns within multi-omics datasets, providing unprecedented insights into the molecular landscape of lung cancer. Due to the heterogeneity, complexity, and high dimensionality of multi-omic cancer data, characterized by the vast number of features (such as gene expression, micro-RNA, and DNA methylation) relative to the limited number of lung cancer patient samples, our prime motivation for this paper is the integration of multi-omic data, unique feature selection, and diagnostic classification of lung subtypes: lung squamous cell carcinoma (LUSC-I) and lung adenocarcinoma (LUAD-II) using quantum machine learning. We developed a method for finding the best differentiating features between LUAD and LUSC datasets, which has the potential for biomarker discovery.
- Open Access
- 29 June 2024
- Published by MDPI AG in Epigenomes
- Vol. 8 (3) , 25
Epigenetic Regulation of Mammalian Cardiomyocyte Development
The heart is the first organ formed during mammalian development and functions to distribute nutrients and oxygen to other parts of the developing embryo. Cardiomyocytes are the major cell types of the heart and provide both structural support and contractile function to the heart. The successful differentiation of cardiomyocytes during early development is under tight regulation by physical and molecular factors. We have reviewed current studies on epigenetic factors critical for cardiomyocyte differentiation, including DNA methylation, histone modifications, chromatin remodelers, and noncoding RNAs. This review also provides comprehensive details on structural and morphological changes associated with the differentiation of fetal and postnatal cardiomyocytes and highlights their differences. A holistic understanding of all aspects of cardiomyocyte development is critical for the successful in vitro differentiation of cardiomyocytes for therapeutic purposes.
- 29 June 2024
- Published by MDPI AG in Epigenomes
- Vol. 8 (3) , 25
Open AccessEpigenetic Regulation of Mammalian Cardiomyocyte Development
The heart is the first organ formed during mammalian development and functions to distribute nutrients and oxygen to other parts of the developing embryo. Cardiomyocytes are the major cell types of the heart and provide both structural support and contractile function to the heart. The successful differentiation of cardiomyocytes during early development is under tight regulation by physical and molecular factors. We have reviewed current studies on epigenetic factors critical for cardiomyocyte differentiation, including DNA methylation, histone modifications, chromatin remodelers, and noncoding RNAs. This review also provides comprehensive details on structural and morphological changes associated with the differentiation of fetal and postnatal cardiomyocytes and highlights their differences. A holistic understanding of all aspects of cardiomyocyte development is critical for the successful in vitro differentiation of cardiomyocytes for therapeutic purposes.
- Open Access
Signaling Pathways Governing Cardiomyocyte Differentiation
Cardiomyocytes are the largest cell type that make up the heart and confer beating activity to the heart. The proper differentiation of cardiomyocytes relies on the efficient transmission and perception of differentiation cues from several signaling pathways that influence cardiomyocyte-specific gene expression programs. Signaling pathways also mediate intercellular communications to promote proper cardiomyocyte differentiation. We have reviewed the major signaling pathways involved in cardiomyocyte differentiation, including the BMP, Notch, sonic hedgehog, Hippo, and Wnt signaling pathways. Additionally, we highlight the differences between different cardiomyocyte cell lines and the use of these signaling pathways in the differentiation of cardiomyocytes from stem cells. Finally, we conclude by discussing open questions and current gaps in knowledge about the in vitro differentiation of cardiomyocytes and propose new avenues of research to fill those gaps.
Open AccessSignaling Pathways Governing Cardiomyocyte Differentiation
Cardiomyocytes are the largest cell type that make up the heart and confer beating activity to the heart. The proper differentiation of cardiomyocytes relies on the efficient transmission and perception of differentiation cues from several signaling pathways that influence cardiomyocyte-specific gene expression programs. Signaling pathways also mediate intercellular communications to promote proper cardiomyocyte differentiation. We have reviewed the major signaling pathways involved in cardiomyocyte differentiation, including the BMP, Notch, sonic hedgehog, Hippo, and Wnt signaling pathways. Additionally, we highlight the differences between different cardiomyocyte cell lines and the use of these signaling pathways in the differentiation of cardiomyocytes from stem cells. Finally, we conclude by discussing open questions and current gaps in knowledge about the in vitro differentiation of cardiomyocytes and propose new avenues of research to fill those gaps.
- Open Access
Cardiomyocyte Differentiation from Mouse Embryonic Stem Cells by WNT Switch Method
The differentiation of ESCs into cardiomyocytes in vitro is an excellent and reliable model system for studying normal cardiomyocyte development in mammals, modeling cardiac diseases, and for use in drug screening. Mouse ESC differentiation still provides relevant biological information about cardiac development. However, the current methods for efficiently differentiating ESCs into cardiomyocytes are limiting. Here, we describe the “WNT Switch” method to efficiently commit mouse ESCs into cardiomyocytes using the small molecule WNT signaling modulators CHIR99021 and XAV939 in vitro. This method significantly improves the yield of beating cardiomyocytes, reduces number of treatments, and is less laborious.
Open AccessCardiomyocyte Differentiation from Mouse Embryonic Stem Cells by WNT Switch Method
The differentiation of ESCs into cardiomyocytes in vitro is an excellent and reliable model system for studying normal cardiomyocyte development in mammals, modeling cardiac diseases, and for use in drug screening. Mouse ESC differentiation still provides relevant biological information about cardiac development. However, the current methods for efficiently differentiating ESCs into cardiomyocytes are limiting. Here, we describe the “WNT Switch” method to efficiently commit mouse ESCs into cardiomyocytes using the small molecule WNT signaling modulators CHIR99021 and XAV939 in vitro. This method significantly improves the yield of beating cardiomyocytes, reduces number of treatments, and is less laborious.
- Open Access
- 19 December 2023
- Published by MDPI AG in Preprints.org
Cardiomyocyte Differentiation from Mouse Embryonic Stem Cells by WNT Switch Method
The differentiation of ESCs into cardiomyocytes in vitro is an excellent and reliable model system for studying normal cardiomyocyte development in mammals, modeling cardiac diseases, and for use in drug screening. Mouse ESC differentiation still provides relevant biological information about cardiac development. However, the current methods for efficiently differentiating ESCs into cardiomyocytes are limiting. Here, we describe a “WNT Switch” method to efficiently commit mouse ESCs into cardiomyocytes using the small molecule WNT signaling modulators CHIR99021 and XAV939 in vitro. This method significantly improves the yield of beating cardiomyocytes, reduces number of treatments, and is less laborious.
- 19 December 2023
- Published by MDPI AG in Preprints.org
Open AccessCardiomyocyte Differentiation from Mouse Embryonic Stem Cells by WNT Switch Method
The differentiation of ESCs into cardiomyocytes in vitro is an excellent and reliable model system for studying normal cardiomyocyte development in mammals, modeling cardiac diseases, and for use in drug screening. Mouse ESC differentiation still provides relevant biological information about cardiac development. However, the current methods for efficiently differentiating ESCs into cardiomyocytes are limiting. Here, we describe a “WNT Switch” method to efficiently commit mouse ESCs into cardiomyocytes using the small molecule WNT signaling modulators CHIR99021 and XAV939 in vitro. This method significantly improves the yield of beating cardiomyocytes, reduces number of treatments, and is less laborious.
- Open Access
- 15 September 2023
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 299 (10) , 105257
Development of a sensitive microplate assay for characterizing RNA methyltransferase activity: Implications for epitranscriptomics and drug development
- 15 September 2023
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 299 (10) , 105257
Open AccessDevelopment of a sensitive microplate assay for characterizing RNA methyltransferase activity: Implications for epitranscriptomics and drug development
- Open Access
- 8 June 2023
- Published by Elsevier in Cell Reports
- Vol. 42 (6) , 112587
Dnmt3bas coordinates transcriptional induction and alternative exon inclusion to promote catalytically active Dnmt3b expression
- 8 June 2023
- Published by Elsevier in Cell Reports
- Vol. 42 (6) , 112587
Open AccessDnmt3bas coordinates transcriptional induction and alternative exon inclusion to promote catalytically active Dnmt3b expression